Fenoldopam in the prevention of contrast media-induced acute renal failure

Annals of Pharmacotherapy

Volumn 35, Issue 10, 2001, Pages 1278-1282

  Chu, V L ^a   Cheng, J W M ^a  

^a Arnold and Marie Schwartz College of Pharmacy   (United States)

Author keywords

Acute renal failure; Contrast media; Fenoldopam

Indexed keywords

CONTRAST MEDIUM; FENOLDOPAM;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE; CLINICAL TRIAL; DRUG INDUCED DISEASE; HUMAN; KIDNEY FUNCTION; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 0034793469     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10375     Document Type: Review

References (34)

1. Medical progress
2. Contrast media-associated nephrotoxocity
3. Early renal medullary hypoxic injury from radiocontrast and indomethacin
4. Induction, prevention and mechanisms of contrast media- induced acute renal failure
5. Acute renal failure following intravenous use of radiographic contrast dyes in patients with diabetes mellitus
6. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
7. Contrast nephrotoxicity
8. Fenoldopam: A dopamine type 1 receptor agonist in the prevention of renal injury associated with the administration of intravascular contrast
9. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: Comparison of low- and high-osmolar contrast agents
10. Contrast medium-induced nephrotoxicity: Pathophysiology and prevention
11. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents
12. Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine
13. Endothelial vasoconstrictor prostanoids, vascular reactivity and acute renal failure
14. Potential of dopamine A1 agonizes in the management of acute renal failure
15. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. study: Prevention of radiocontrast induced nephropathy clinical evaluation
16. Use of dopamine in prevention of contrast induced acute renal failure - A randomized study
17. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency
18. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
19. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography
20. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension
21. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function
22. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
23. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients
24. Prophylactic efficacy of fenoldopam in radiocontrast nephropathy: A randomized double-blind, placebo-controlled trial
25. Managing the high-risk patients: Experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention
26. Fenoldopam: A review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies
27. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis
28. Selective dopamine-agonist therapy in severe hypertension: Effects of intravenous fenoldopam
29. Renal failure after major angiography can be avoided with hydration
30. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast-media application
31. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy
32. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus